ID
Idorsia Ltd
IDRSF · OTC
$6.13 +0.00% (+$0.00)
1M -5.69%
Market Cap CHF 1.28B
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
21 /100
Expensive P/S 6.43x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 31.56%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 78.89%
Net margin 158.74%
FCF margin 65.28%
Quality
8 /100
Poor ROIC 47.82%
ROA 68.28%
Asset turnover 0.43x
Debt
6 /100
High Current ratio 0.58x
Int. coverage 0.18x
Debt/Equity N/A
Stability
26 /100
Unstable Beta 1.66x
Rev. volatility 62.62%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o IDRSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jean-Paul Clozel
Employees
487
Headquarters
Allschwil
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report